Difference between revisions of "Product IG DSR"
(New page: =Product Brief- eStability R2 IG= __TOC__ back to Main_Page<br/> back to Product List =Product Name - eStability R2 IG= *HL7 Version 3 Implementation Guide: Drug Stability Repor...) |
|||
| Line 12: | Line 12: | ||
===Releases=== | ===Releases=== | ||
| − | Release 2 - January 2009 | + | HL7 IG DSR, R2; Release 2 - January 2009 |
===Summary=== | ===Summary=== | ||
Latest revision as of 17:32, 6 November 2009
Product Brief- eStability R2 IG
Contents
back to Main_Page
back to Product List
Product Name - eStability R2 IG
- HL7 Version 3 Implementation Guide: Drug Stability Reporting (eStability), Release 2
Type
Informative
Releases
HL7 IG DSR, R2; Release 2 - January 2009
Summary
This Implementation Guide (IG) is for the use of the Health Level 7 (HL7) Stability Standard. The IG describes the basic requirements needed for using the standard and the requirements needed for submitting information to the Food and Drug Administration (FDA) using the standard. The HL7 Stability Standard is for one way communication between contractor to company, company to company, company to regulatory agency.
Business Case (Intended Use, Customers)
The standard can be used to report results of stability studies carried out on a drug product to a Regulatory Authority. Additionaly the standard can be used to update the results of a previously submitted study or withdraw a previously submitted study.
Uses of this standard indlude
- FDA,
- Pharmaceutical Companies,
- Veternary drug Products Companies
Benefits
Provides a digital representation of stability testing results as compared to current practice of submitting report documents.
Implementations/ Case Studies (Actual Users)
Currently utilized in DSTU between FDA and industry users
Resources
FDA
Website
Work Groups
- HL7 Website RCRIM
- HL7 Wiki RCRIM Drug Stability Reporting
Relationship to/ Dependencies on, other standards
- None
Links to current projects in development
